{\rtf1 \ansi 
{\colortbl;
\red0\green0\blue0;
\red255\green255\blue255;
\red255\green0\blue0;
\red0\green255\blue0;
\red0\green0\blue255;
\red0\green255\blue255;
\red255\green0\blue255;
\red255\green255\blue0;
\red0\green0\blue128;
\red0\green128\blue128;
\red0\green128\blue0;
\red128\green0\blue128;
\red128\green0\blue0;
\red128\green128\blue0;
\red128\green128\blue128;
\red192\green192\blue192;
}
{\fonttbl {
\f0 Arial;}{
\f1 Symbol;}{
\f2 Times New Roman;}{
\f3 sans-serif;}
}
{\*\generator Apache XML Graphics RTF Library;}
\fet0 \ftnbj \paperw11905 \paperh16837 \margt1417 \margb1417 \margl1417 \margr1417 \headery1417 \footery1417 \itap0 
\sectd {
{\trowd \itap0 \trleft0 
\clbrdrt \clbrdrb \clbrdrl \trql \cellx4507 
\clbrdrt \clbrdrb \clbrdrr \trql \cellx9014 
\intbl 
{\b0 \cf1 \f3 \ri0 \i1 \ql \fs32 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs32 \sa0 \sb0 
ART. 6
\cell 
}
}\b0 \cf1 \f3 \ri0 \ul0 \strike0 \i1 \ql \fs32 \li0 \sa0 \sb0 \intbl \intbl 
{\qr \b0 \cf1 \f3 \ri0 \i1 \fs32 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs32 \sa0 \sb0 
N\u176\'3f1324
\cell 
}
}\qr \b0 \cf1 \f3 \ri0 \ul0 \strike0 \i1 \fs32 \li0 \sa0 \sb0 \intbl \row }}
{\b1 \qc \cf1 \f3 \ri0 \i0 \fs48 \li0 
{\b1 \cf1 \f3 \ul0 \strike0 \i0 \fs48 \sa0 \sb0 
ASSEMBL\u201\'3fE NATIONALE
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i1 \fs32 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs32 \sa0 \sb0 
12 F\u233\'3fvrier 2026
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
___________________________________________________________________
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i1 \fs32 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs32 \sa0 \sb400 
DROIT \u192\'3f L\rquote AIDE \u192\'3f MOURIR - (N\u176\'3f 2453)
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs24 \li0 
}
{\b0 \qc \cf1 \f2 \ri0 \i1 \fs24 \li0 
}
{\b1 \cf1 \f3 \ri0 \i0 \ql \fs36 \li400 
{\b1 \cf1 \f3 \ul0 \strike0 \i0 \fs36 \sa0 \sb200 
Rejet\u233\'3f
\par 
}
}
{\b1 \qc \cf1 \f3 \ri200 \i1 \fs36 \li200 
{\b1 \cf1 \f3 \ul0 \strike0 \i1 \fs36 \sa200 \sb200 
AMENDEMENT N\u176\'3f1324
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb200 
pr\u233\'3fsent\u233\'3f par
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i1 \fs20 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i1 \fs20 \sa0 \sb0 
Mme\u160\'3fColin-Oesterl\u233\'3f, M.\u160\'3fLam, Mme\u160\'3fLise\u160\'3fMagnier, Mme\u160\'3fGruet, M.\u160\'3fBerrios et M.\u160\'3fBenoit
\par 
}
}
{\b0 \qc \cf1 \f3 \ri0 \i0 \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
------------
\par 
}
}
{\b1 \qc \cf1 \f3 \ri0 \i1 \fs24 \li0 
{\b1 \cf1 \f3 \ul0 \strike0 \i1 \fs24 \sa0 \sb0 
ARTICLE 6
\par 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
Compl\u233\'3fter l\u8217\'3falin\u233\'3fa\u160\'3f19 par laphrase suivante\u160\'3f:\u160\'3f
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
\u171\'3f\u160\'3fLa dur\u233\'3fe de validit\u233\'3f de laprescription de la substance l\u233\'3ftale est de trois mois.\u160\'3f\u187\'3f
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
}
{\b1 \qc \cf1 \f3 \ri0 \i0 \fs24 \li0 
{\b1 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa0 \sb0 
EXPOS\u201\'3f SOMMAIRE
\par 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
Le pr\u233\'3fsent amendement vise \u224\'3f encadrer dans le temps la validit\u233\'3fde la prescription de la substance l\u233\'3ftale, en la limitant \u224\'3f unedur\u233\'3fe maximale de trois mois.
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
Cette pr\u233\'3fcision r\u233\'3fpond \u224\'3f une exigence de s\u233\'3fcurit\u233\'3f et de prudencem\u233\'3fdicale. La situation clinique d\u8217\'3fune personne atteinte d\u8217\'3funepathologie grave et incurable en phase avanc\u233\'3fe ou terminale est,par nature, \u233\'3fvolutive. L\u8217\'3f\u233\'3ftat g\u233\'3fn\u233\'3fral du patient, l\u8217\'3fintensit\u233\'3f dessympt\u244\'3fmes, les traitements concomitants, ainsi que les conditionsd\u8217\'3fadministration de la substance peuvent conna\u238\'3ftre desmodifications significatives en l\u8217\'3fespace de quelques semaines.
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
Ces \u233\'3fvolutions sont susceptiblesd\u8217\'3favoir des incidences directes sur les modalit\u233\'3fs pratiques de miseen \u339\'3fuvre de la prescription, notamment en ce qui concerne laposologie, la voie d\u8217\'3fadministration (injection intraveineuse,ingestion orale ou autre modalit\u233\'3f autoris\u233\'3fe), ou encore lesconditions mat\u233\'3frielles et humaines d\u8217\'3faccompagnement.
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
{\b0 \cf1 \f3 \ri0 \i0 \ql \fs24 \li0 
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 \sa240 \sb240 
Cet amendement a \u233\'3ft\u233\'3f travaill\u233\'3f avec leCNOM
\par 
}
}
{\b0 \cf1 \f3 \ul0 \strike0 \i0 \fs24 
}
}
{\b0 \cf1 \f3 \ri0 \i0 \qj \fs24 \li0 
}
{\b0 \cf1 \sbkpage \f3 \sect \ri0 \i0 \ql \fs24 \li0 
}}